Avidity Partners Management LP 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 9:44 pm Sale |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 3,950,000 4.700% |
-2,768,142 (-41.20%) |
Filing |
| 2023-02-14 3:47 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 6,718,142 9.700% |
1,474,123 (+28.11%) |
Filing |
| 2022-02-11 8:54 pm Purchase |
2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 5,244,019 9.900% |
494,019 (+10.40%) |
Filing |
| 2021-04-20 4:34 pm Purchase |
2021-04-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 4,750,000 9.900% |
1,442,000 (+43.59%) |
Filing |
| 2021-02-16 11:32 am Purchase |
2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 3,308,000 7.100% |
708,000 (+27.23%) |
Filing |
| 2020-11-04 5:05 pm Purchase |
2020-11-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 2,600,000 6.700% |
2,600,000 (New Position) |
Filing |